References
- Weng CH, Hu CC, Lin JL, et al. Sequential organ failure assessment score can predict mortality in patients with paraquat intoxication. PLoS One. 2012;7:e51743.
- Smith P, Heath D. The pathology of the lung in paraquat poisoning. J Clin Pathol Suppl (R Coll Pathol). 1975;9:81–93.
- Riahi B, Rafatpanah H, Mahmoudi M, et al. Evaluation of suppressive effects of paraquat on innate immunity in Balb/c mice. J Immunotoxicol. 2011;8:39–45.
- Ma J, Li Y, Niu D, et al. Immunological effects of paraquat on common carp, Cyprinus carpio L. Fish Shellfish Immunol. 2014;37:166–172.
- Hu L, Yu Y, Huang H, et al. Epigenetic regulation of interleukin 6 by histone acetylation in macrophages and its role in paraquat-induced pulmonary fibrosis. Front Immunol. 2017;7:696.
- Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44:450–462.
- Wu WP, Lai MN, Lin CH, et al. Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: a nationwide study. PLoS One. 2014;9:e87568.
- Zhang J, Zhao Y, Bai Y, et al. The significance of serum uric acid level in humans with acute paraquat poisoning. Sci Rep. 2015;5:9168.
- Gasse P, Riteau N, Charron S, et al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med. 2009;179:903–913.
- Tsai JL, Chen CH, Wu MJ, et al. Paraquat poisoning in patients with HIV infection: A case report and literature review. Medicine (Baltimore). 2016;95:e3350.
- Rose MS, Lock EA, Smith LL, et al. Paraquat accumulation: tissue and species specificity. Biochem Pharmacol. 1976;25:419–423.
- Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826–837.
- Hara Y, Shimomura Y, Nakamura T, et al. Novel blood purification system for regulating excessive immune reactions in severe sepsis and septic shock: an ex vivo pilot study. Ther Apher Dial. 2015;19:308–315.
- Dignass A, Akbar A, Hart A, et al. Safety and efficacy of granulocyte/monocyte apheresis in steroid-dependent active ulcerative colitis with insufficient response or intolerance to immunosuppressants and/or biologics [the ART Trial]: 12-week interim results. J Crohns Colitis. 2016;10:812–820.